The Power of 60 Million: Accelerating Late Stage Clinical Trials
Monday, October 14, 2013 from 9:30 AM to 6:00 PM (EDT)
9.30-10.00 Registration, networking and welcome address
10.00-11.00 The Clinical Research Network: enabling rapid site initiation and patient recruitment
Dr. Jonathan Sheffield OBE – CEO, National Institute for Health Research (NIHR) Clinical Research Network, and Richard Corbridge, Chief Information Officer.
11.00-12.00 BIG DATA: Accessing anonymized, population-wide health data to supercharge clinical research
Maggie Massam – Head of Business Development, Clinical Practice Research Datalink (CPRD)
12.00 – 1.30 Lunch and Networking
1.30 – 2.30 Rapid adoption of healthcare innovation – why companies should register details of late-stage pipeline products
Derek Ward, MD – Co-Director, NIHR Horizon Scanning Centre
2.30-3.30 NICE – Here to help. Technology Appraisal, value based pricing (VBP) and Scientific Advice
Leeza Osipenko, Ph.D. – Senior Scientific Adviser, NICE Scientific Advice, National Institute for Health and Care Excellence (NICE)
3.30-4.30 Panel discussion with NICE and selected industry leaders from the Boston biotech community - Sponsored by Alacrita Consulting
4.30-6.00 Traditional Afternoon Tea will be served
When & Where
UK Trade & Investment
UK Trade & Investment (UKTI) is the British Government Department that helps US and UK based companies to fast-track the investigation, development and excellence of trans-Atlantic business operations.
For further information please visit: www.ukti.gov.uk.